{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/60b1306d44938a0013db19cf/6164756a0f8c430012cc7a4e?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Showing the value of regulatory intelligence in pharma ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/60b1306d44938a0013db19cf/1623315228296-0f6d70af5a62181f19e3343e22b64ea2.jpeg?height=200","description":"<p>In this episode of Conversations in Healthcare, Mike Ward&nbsp;speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca,&nbsp;and Céline Rodier, Senior Health Policy Manager at Clarivate,&nbsp;about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. Get actionable takeaways in the full episode.&nbsp;&nbsp;</p>","author_name":"Clarivate"}